BACKGROUND AND AIM OF THE STUDY: Hurler syndrome (mucopolysaccharidosis type I/H; MPS I/H) is a lethal heritable enzymopathy that leads to an accumulation of glycosaminoglycans (GAGs) and dysfunction of multiple organs of the body, including the heart. As gender-related differences are common in heart disease and a murine model for mucopolysaccharidosis type I (MPSI) has been used for the preclinical evaluation of strategies to correct heart valve disease in Hurler syndrome, the study aim was to determine the impact of gender on heart disease in the murine MPSI model. METHODS: Murine hearts were examined by high-resolution ultrasound biomicroscopy, the tissue and urinary contents of GAGs were measured, and the quantitative reverse transcribed ribonucleic acid polymerase chain reaction for metalloproteinase (MMP) -9 and -12 determined. RESULTS: In MPSI mice, aortic insufficiency (AI) in conjunction with depressed myocardial function was observed significantly more often in males than females. Neither the total body GAG burden nor myocardial GAG content was responsible for this difference. In contrast, in the aorta the expression of extracellular matrix tissue MMP-12, but not MMP-9, was significantly elevated in males with AI when compared to females with AI. CONCLUSION: Gender-related dimorphism occurs in cardiac valvular disease in MPSI mice. Male MPSI mice showed an increased incidence of AI associated with an increase in the MMP-12 content of the aortic arch. The evaluation of findings in relation to gender is important in the experimental treatment of murine models of disease, so that gender-related variations in genetic penetrance are not mistaken for disease correction.
BACKGROUND AND AIM OF THE STUDY: Hurler syndrome (mucopolysaccharidosis type I/H; MPS I/H) is a lethal heritable enzymopathy that leads to an accumulation of glycosaminoglycans (GAGs) and dysfunction of multiple organs of the body, including the heart. As gender-related differences are common in heart disease and a murine model for mucopolysaccharidosis type I (MPSI) has been used for the preclinical evaluation of strategies to correct heart valve disease in Hurler syndrome, the study aim was to determine the impact of gender on heart disease in the murine MPSI model. METHODS:Murine hearts were examined by high-resolution ultrasound biomicroscopy, the tissue and urinary contents of GAGs were measured, and the quantitative reverse transcribed ribonucleic acid polymerase chain reaction for metalloproteinase (MMP) -9 and -12 determined. RESULTS: In MPSI mice, aortic insufficiency (AI) in conjunction with depressed myocardial function was observed significantly more often in males than females. Neither the total body GAG burden nor myocardial GAG content was responsible for this difference. In contrast, in the aorta the expression of extracellular matrix tissue MMP-12, but not MMP-9, was significantly elevated in males with AI when compared to females with AI. CONCLUSION: Gender-related dimorphism occurs in cardiac valvular disease in MPSI mice. Male MPSI mice showed an increased incidence of AI associated with an increase in the MMP-12 content of the aortic arch. The evaluation of findings in relation to gender is important in the experimental treatment of murine models of disease, so that gender-related variations in genetic penetrance are not mistaken for disease correction.
Authors: Elizabeth Braunlin; Shannon Mackey-Bojack; Angela Panoskaltsis-Mortari; James M Berry; Ron T McElmurry; Megan Riddle; Li-Yan Sun; Lorne A Clarke; Jakub Tolar; Bruce R Blazar Journal: Pediatr Res Date: 2005-12-02 Impact factor: 3.756
Authors: Gregory M Pastores; Pamela Arn; Michael Beck; Joe T R Clarke; Nathalie Guffon; Paige Kaplan; Joseph Muenzer; Denise Y J Norato; Elsa Shapiro; Janet Thomas; David Viskochil; J Edmond Wraith Journal: Mol Genet Metab Date: 2007-03-02 Impact factor: 4.797
Authors: Alaina K Natoli; Tanya L Medley; Anna A Ahimastos; Brian G Drew; Daniel J Thearle; Rodney J Dilley; Bronwyn A Kingwell Journal: Hypertension Date: 2005-10-17 Impact factor: 10.190
Authors: Oscar H Grandas; Deidra J H Mountain; Stacy S Kirkpatrick; Vivek S Rudrapatna; David C Cassada; Scott L Stevens; Michael B Freeman; Mitchell H Goldman Journal: J Surg Res Date: 2008-04-09 Impact factor: 2.192
Authors: Xiucui Ma; Mindy Tittiger; Russell H Knutsen; Attila Kovacs; Laura Schaller; Robert P Mecham; Katherine P Ponder Journal: Mol Genet Metab Date: 2008-05-13 Impact factor: 4.797
Authors: Mark J Osborn; Beau R Webber; Ronald T McElmurry; Kyle D Rudser; Anthony P DeFeo; Michael Muradian; Anna Petryk; Benedikt Hallgrimsson; Bruce R Blazar; Jakub Tolar; Elizabeth A Braunlin Journal: J Inherit Metab Dis Date: 2016-10-14 Impact factor: 4.982
Authors: Gwen Gunn; Yanying Dai; Ming Du; Valery Belakhov; Jeyakumar Kandasamy; Trenton R Schoeb; Timor Baasov; David M Bedwell; Kim M Keeling Journal: Mol Genet Metab Date: 2013-12-17 Impact factor: 4.797
Authors: Elizabeth Braunlin; Juan E Abrahante; Ron McElmurry; Michael Evans; Miles Smith; Davis Seelig; M Gerard O'Sullivan; Jakub Tolar; Chester B Whitley; R Scott McIvor Journal: Mol Genet Metab Date: 2022-02-03 Impact factor: 4.204
Authors: Mark J Osborn; Ron T McElmurry; Christopher J Lees; Anthony P DeFeo; Zhi-Ying Chen; Mark A Kay; Luigi Naldini; Gordon Freeman; Jakub Tolar; Bruce R Blazar Journal: Mol Ther Date: 2010-11-16 Impact factor: 11.454
Authors: D A Wolf; A W Lenander; Z Nan; E A Braunlin; K M Podetz-Pedersen; C B Whitley; P Gupta; W C Low; R S McIvor Journal: Bone Marrow Transplant Date: 2011-12-19 Impact factor: 5.483